Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort-Reference-Cited by-同舟云学术

Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort

Published:2016 Issue:6 Volume:1 Page:e000154
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Burris Howard A.,Bakewell Suzanne,Bendell Johanna C.,Infante Jeffrey,Jones Suzanne F.,Spigel David R.,Weiss Glen J.,Ramanathan Ramesh K.,Ogden Angela,Von Hoff Daniel

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Cisplatin resistance and oncogenes--a review;Dempke;Anticancer Drugs,2000

2. Molecular mechanisms of cisplatin resistance;Galluzzi;Oncogene,2012

3. Gallium and other main group metal compounds as antitumor agents;Jakupec,2004

4. Recent developments in the field of tumor-inhibiting metal complexes;Galanski;Curr Pharm Des,2003

5. Ruthenium complexes: an emerging ground to the development of metallopharmaceuticals for cancer therapy;Abid;Mini Rev Med Chem,2015

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, electrochemical, biological and catalytical studies of half-sandwich Ru(II)-NSHC complexes bearing benzothiazol-2-ylidene;Journal of Molecular Structure;2024-12

2. Endoplasmic reticulum stress in diseases;MedComm;2024-08-26

3. Plectin-mediated cytoskeletal crosstalk as a target for inhibition of hepatocellular carcinoma growth and metastasis;2024-08-06

4. Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides—Current Developments in Structure-Activity Relationship;International Journal of Molecular Sciences;2024-07-03

5. Overcoming Resistance of Caco-2 Cells to 5-Fluorouracil through Diruthenium Complex Encapsulation in PMMA Nanoparticles;Inorganic Chemistry;2024-06-04